Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,120.12
(
-0.26%
)
US TECH 100
26,388.00
(
0.33%
)
Dow Jones
48,743.77
(
-0.81%
)
Brent Oil
110.48
(
5.81%
)
Bitcoin
75,457.93
(
-1.16%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122905
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 250417

Tuesday, 03/11/2025 3:00:42 AM

Tuesday, March 11, 2025 3:00:42 AM

Post# of 257465
BMY acquires TSVT for $3.00/sh cash—a 79% premium to yesterday’s close:

https://www.businesswire.com/news/home/20250310482749/en

The nominal deal value is a $102M.

BMY and TSVT are partners on Abecma. TSVT divested all non-Abecma assets in Jan 2024 for a paltry $5M (#msg-173732133).

TSVT is the 2021 oncology spinoff from BLUE. BLUE itself was acquired by a private equity firm in a Feb 2025 takeunder (#msg-175838971.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today